Gambaran Umum
Immutep Limited is an Australian biotechnology company that specializes in the development of immunotherapy treatments for cancer and autoimmune diseases. Founded in 1987 and headquartered in Sydney, Immutep is at the forefront of advancing immunotherapeutic products that harness the body’s immune system. Its key projects focus on the proprietary LAG-3 (Lymphocyte Activation Gene-3) technology, which has yielded multiple product candidates, including eftilagimod alpha (IMP321), positioned as a potential enhancer of the immune response to various tumors. Additionally, Immutep’s pipeline includes multiple partnerships with major pharmaceutical companies aimed at co-developing and commercializing their immunotherapeutic compounds, demonstrating significant investment in research and potential for growth in oncology and beyond.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Immutep Limited per 2025 Jun 30 adalah 5.04 MM.
- Nilai operating income untuk Immutep Limited per 2025 Jun 30 adalah -65.01 MM.
- Nilai net income untuk Immutep Limited per 2025 Jun 30 adalah -61.43 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 5.04 | -65.01 | -61.43 |
2025-03-31 | 4.96 | -57.43 | -52.65 |
2024-12-31 | 4.88 | -49.85 | -43.87 |
2024-09-30 | 4.36 | -48.20 | -43.29 |
2024-06-30 | 3.84 | -46.56 | -42.72 |
2024-03-31 | 3.89 | -44.85 | -41.61 |
2023-12-31 | 3.93 | -43.14 | -40.50 |
2023-09-30 | 3.72 | -42.28 | -40.20 |
2023-06-30 | 3.51 | -41.43 | -39.90 |
2023-03-31 | 3.91 | -39.92 | -38.23 |
2022-12-31 | 4.32 | -38.42 | -36.56 |
2022-09-30 | 4.52 | -36.13 | -34.39 |
2022-06-30 | 4.71 | -33.84 | -32.21 |
2022-03-31 | 4.22 | -29.97 | -29.27 |
2021-12-31 | 3.73 | -26.11 | -26.33 |
2021-09-30 | 3.80 | -22.88 | -28.12 |
2021-06-30 | 3.86 | -19.66 | -29.90 |
2021-03-31 | 5.11 | -19.38 | -28.63 |
2020-12-31 | 6.35 | -19.11 | -27.36 |
2020-09-30 | 10.05 | -17.09 | -20.42 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -0.03 | -0.03 |
2024-09-30 | -0.03 | -0.03 |
2024-06-30 | -0.04 | -0.04 |
2024-03-31 | -0.04 | -0.04 |
2023-12-31 | -0.04 | -0.04 |
2023-09-30 | -0.04 | -0.04 |
2023-06-30 | -0.04 | -0.04 |
2023-03-31 | -0.04 | -0.04 |
2022-12-31 | -0.04 | -0.04 |
2022-09-30 | -0.04 | -0.04 |
2022-06-30 | -0.04 | -0.04 |
2022-03-31 | -0.04 | -0.04 |
2021-12-31 | -0.03 | -0.03 |
2021-09-30 | -0.04 | -0.04 |
2021-06-30 | -0.05 | -0.05 |
2021-03-31 | -0.05 | -0.05 |
2020-12-31 | -0.06 | -0.06 |
2020-09-30 | -0.05 | -0.05 |
2020-06-30 | -0.03 | -0.03 |
2020-03-31 | -0.04 | -0.04 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Immutep Limited per 2025 Jun 30 adalah -62.05 MM.
- Nilai cash from investing activities untuk Immutep Limited per 2025 Jun 30 adalah -38.53 MM.
- Nilai kas dari aktivitas pendanaan untuk Immutep Limited per 2025 Jun 30 adalah -0.53 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -62.05 | -38.53 | -0.53 |
2025-03-31 | -53.48 | -60.97 | 47.33 |
2024-12-31 | -44.92 | -83.41 | 95.18 |
2024-09-30 | -39.87 | -52.22 | 95.18 |
2024-06-30 | -34.82 | -21.02 | 95.18 |
2024-03-31 | -38.36 | -10.73 | 85.44 |
2023-12-31 | -41.89 | -0.44 | 75.70 |
2023-09-30 | -38.62 | -0.26 | 75.86 |
2023-06-30 | -35.36 | -0.08 | 76.02 |
2023-03-31 | -32.86 | -0.08 | 37.90 |
2022-12-31 | -30.36 | -0.08 | -0.21 |
2022-09-30 | -30.29 | -0.05 | 25.06 |
2022-06-30 | -30.23 | -0.02 | 50.33 |
2022-03-31 | -25.31 | -0.02 | 57.40 |
2021-12-31 | -20.39 | -0.02 | 64.48 |
2021-09-30 | -19.02 | -0.02 | 58.58 |
2021-06-30 | -17.64 | -0.02 | 52.68 |
2021-03-31 | -16.16 | -0.01 | 51.30 |
2020-12-31 | -14.67 | -0.01 | 49.92 |
2020-09-30 | -12.76 | -0.01 | 35.20 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Immutep Limited pada 2025 Jun 30 adalah -0.22.
- roe untuk Immutep Limited pada 2025 Jun 30 adalah -0.23.
- roic untuk Immutep Limited pada 2025 Jun 30 adalah -0.25.
- croic untuk Immutep Limited pada 2025 Jun 30 adalah -0.17.
- ocroic untuk Immutep Limited pada 2025 Jun 30 adalah -0.26.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.22 | -0.23 | -0.25 | -0.17 | -0.26 |
2025-03-31 | -0.22 | -0.23 | -0.25 | -0.17 | -0.26 |
2024-12-31 | -0.35 | -0.37 | -0.22 | 0.20 | -0.18 |
2024-09-30 | -0.35 | -0.37 | -0.22 | 0.20 | -0.18 |
2024-06-30 | -0.30 | ||||
2024-03-31 | -0.53 | ||||
2023-12-31 | -0.35 | 0.34 | |||
2023-09-30 | -0.29 | 0.32 | |||
2023-06-30 | -0.42 | ||||
2023-03-31 | -0.41 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | ||||
2021-09-30 | -0.37 | -0.46 | |||
2021-06-30 | -0.64 | -0.39 | 0.45 | -0.23 | |
2021-03-31 | -0.61 | -0.86 | -0.38 | 0.45 | -0.21 |
2020-12-31 | -0.64 | -0.98 | -0.39 | 0.49 | -0.21 |
2020-09-30 | -0.48 | -0.73 | -0.29 | 0.31 | -0.18 |
2020-06-30 | -0.33 | -0.55 | -0.32 | 0.23 | -0.26 |
2020-03-31 | -0.36 | -0.60 | -0.34 | 0.05 | -0.30 |
Gross Margins
- marjin kotor untuk Immutep Limited pada 2025 Jun 30 adalah -8.52.
- marjin bersih untuk Immutep Limited pada 2025 Jun 30 adalah -8.99.
- marjin operasi untuk Immutep Limited pada 2025 Jun 30 adalah -10.22.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | -8.52 | -8.99 | -10.22 |
2025-03-31 | -8.52 | -8.99 | -10.22 |
2024-12-31 | -9.81 | -11.12 | -12.12 |
2024-09-30 | -9.81 | -11.12 | -12.12 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | -11.38 | -11.82 | |
2023-06-30 | -11.38 | -11.82 | |
2023-03-31 | -9.77 | -10.21 | |
2022-12-31 | |||
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | -3.46 | -7.74 | -5.09 |
2021-03-31 | -2.55 | -5.61 | -3.79 |
2020-12-31 | -1.67 | -4.31 | -3.01 |
2020-09-30 | -0.86 | -2.03 | -1.70 |
2020-06-30 | -0.48 | -0.98 | -1.10 |
2020-03-31 | -0.55 | -1.09 | -1.17 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1506184 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |